This book provides with its readers an objective overview of the latest development of China's special economic zones in 2019. It aims to inform researchers what achievements have been attained in one year and tells stories to general readers about how to address economic concerns through public policies. Its case studies illustrate economic achievements attained in public health, social security, and cultural industries. Its in-depth analyses of green, environmental-friendly, and resource-efficient policies can satisfy the curiosity about strategies applied by China meeting its economic challenges.

This book provides with its readers an objective overview of the latest development of China’s special economic zones in 2019. It aims to inform researchers what achievements have been attained in one year and tells stories to general readers about how to address economic concerns through public policies. Its case studies illustrate economic achievements attained in public health, social security, and cultural industries. Its in-depth analyses of green, environmental-friendly, and resource-efficient policies can satisfy the curiosity about strategies applied by China meeting its economic challenges.  

Preeclampsia is a hypertensive disorder of pregnancy. It affects the health of both mother and fetus, and increases a woman's later cardiovascular risk.Normally during pregnancy, the immune system changes and women become more susceptible to infectious agents. Two infectious agents in particular, C. pneumonia and CMV, are thought to trigger early onset preeclampsia and have been linked to the development of cardiovascular disease later in life. However, it is still unclear what role they play in the onset and development of preeclampsia.Dr. Xie is investigating the mechanisms between infection, innate immune response and the development of preeclampsia. In the present work, she studied how pregnant women are affected by these two infectious agents and how immune system responds to the infection, including examination of TLR signaling and immune genetic variations that may increase disease susceptibility. Results from her work will assist to identify novel therapeutic targets for unfavorable pregnancy outcome management and later cardiovascular disease prevention, leading to improved health care for both mother and fetus.